Areas of Focus
- Laboratory diagnosis of viral hepatitis
- HBV infection and hepatocellular carcinoma mechanisms
Work Experience
- 1994-1997 - Peking University Third Hospital, Central Laboratory
- 1997-2005 - Studied abroad at Karolinska Institute and University of Pennsylvania
- 2006-present - Professor at Peking University Health Science Center
Academic Background & Achievements
- 1986 Graduated from Henan Medical University, Clinical Medicine
- 1989 Master's in Medical Genetics, Harbin Medical University
- 1992 PhD in Medical Genetics, Harbin Medical University
- Postdoctoral research at Peking University, Public Health and Preventive Medicine (1992-1994)
Publications
- Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population, Lu Fengmin, 2011
- Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma, Lu Fengmin, 2011
- A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients, Lu Fengmin, 2011
- Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients, Lu Fengmin, 2011
- Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine, Lu Fengmin, 2011
- PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients, Lu Fengmin, 2010
- SOX17 antagonizes WNT/beta-catenin signaling pathway in hepatocellular carcinoma, Lu Fengmin, 2010
- Epidemiology and prevention of hepatitis B virus infection in China, Lu Fengmin, 2010
- Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection, Lu Fengmin, 2010
- Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection, Lu Fengmin, 2010
- Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients, Lu Fengmin, 2010
Awards
- National Science and Technology Progress Second Prize for research in viral hepatitis